Efficacy and safety of direct acting antiviral regimens for hepatitis C virus and human immunodeficiency virus co-infection: systematic review and network meta-analysis.
Yi-Xiang ZhengShu-Juan MaYing-Hui XiongXue-Gong FanPublished in: Journal of gastroenterology and hepatology (2020)
Efficacy and safety of all-oral DAAs were in prospect for HIV/HCV co-infection patients. GZR/EBR ± RBV was the optimal combination recommended for HIV/HCV co-infected patients based on the excellent treatment effects and insignificant adverse events.
Keyphrases
- hepatitis c virus
- human immunodeficiency virus
- antiretroviral therapy
- end stage renal disease
- hiv positive
- hiv infected
- hiv aids
- newly diagnosed
- ejection fraction
- chronic kidney disease
- hiv testing
- peritoneal dialysis
- prognostic factors
- patient reported
- current status
- patient reported outcomes
- south africa
- combination therapy